Oncology Clinical Trial Disruption During the COVID-19 Pandemic: a COVID-19 and Cancer Outcomes Study
Z. Bakouny,C. Labaki,S. Bhalla,A. L. Schmidt,J. A. Steinharter, J. Cocco,D. A. Tremblay,M. M. Awad,A. Kessler,R. Haddad,M. Evans,F. Busser,M. Wotman,C. R. Curran,B. S. Zimmerman,G. Bouchard,T. Jun,P. Nuzzo,Q. Qin,L. Hirsch,J. Feld,K. M. Kelleher,D. Seidman,H. Huang,H. M. Anderson-Keightly,T. El Zarif,S. Abou Alaiwi, C. Champagne,T. D. Rosenbloom,P. S. Stewart,B. E. Johnson,Q. Trinh,S. M. Tolaney,M. D. Galsky,T. K. Choueiri,D. B. Doroshow Cancer Cell（2020）
Key words
clinical trials,COVID-19,cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper